Press Release
Campo Indictment Exposes DEA Rotted From Within - While Medical Cannabis Research and Patients Wait Seven Years
A Federal Indictment That Reads Like a Narco-State Thriller DEA corruption reaches new levels with the Campo indictment, even as the agency continues its unprecedented seven-year delay of MMJ International Holding's FDA sanctioned clinical trial program. for Huntington's Disease. President Trump and Terry Cole cleaning out the DEA corruption. Read More
Press Release
BCII Enterprises Inc. Launches Coupon Token System: 2% Mortgage Discounts for 46m Renters, Down-Payment Grants for Exercising Users, 10% Tax Relief for 175m Americans, and Corporate Token Buy-Ins Targeting Deficit Elimination in 18 Months
Patent-Pending Coupon Token Architecture Demonstrates Unprecedented Scalability Across Housing, Tax Policy, and Corporate Finance Creating Multi-Billion Dollar Revenue Opportunity for BCII Read More
Press Release
CXAI Announces Results from Landmark Enterprise Deployment as Global Workplace Disruption Creates an up to Trillion Dollar Agentic AI Opportunity For Employee Engagement
Enterprise adoption accelerates as CXAI strengthens its position at the center of the workplace experience and enterprise Agentic AI markets Read More
Press Release
SETO Holdings,Inc Acquires CapCity Beverage, LLC to Strengthen U.S. Importation, Distribution Infrastructure, and Brand Acceleration
The acquisition solidifies SETO's control over U.S. importation, compliance, and national distribution-positioning the company to scale its brand portfolio with greater speed, efficiency, and market access. Read More
Press Release
Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025
100% of patients in Cohorts 1-3 remain free of cytokine release syndrome CRIS-7-derived CD3 design underpins a controlled T-cell response, supporting the differentiated safety profile, combinability with standard of care Read More
Press Release
Anew Climate and Aurora Sustainable Lands Issue Carbon Credits Under ACR's IFM 2.1 Methodology, Setting a New Standard for Forest Carbon Integrity
Aurora Sustainable Lands and Anew Climate combine proven land stewardship and innovative, technology-driven carbon quantification to deliver verifiable climate benefits Read More
Press Release
Jaguar Health Reports Approval of All Proposals at December 2025 Special Meeting of Stockholders
Jaguar CEO Lisa Conte presenting December 10 from 3:25pm - 3:35pm Eastern at the Emerging Growth Conference to provide updates on near-term catalysts; Click here to register Initial results of ongoing investigator-initiated proof-of-concept trial demonstrate crofelemer can potentially extend the lives of infants born with intestinal failure due to microvillus inclusion disease (MVID), reducing the volume of the total parenteral support (PS) necessary for them to survive, though with associated toxicity; Groundbreaking PS reduction of up to 37%; No approved treatments exist for MVID Company completed meeting with FDA October 2, 2025 for advice on advancing its ongoing placebo-controlled trial of crofelemer in support of possible expedited approval pathway for crofelemer for treatment of MVID Read More
Press Release
